Search for "RibX" - 2/5

by in

Entry	Author	Date	Location
Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy	Luke Timmerman	02/16/10	Boston
Rib-X Founder Gets Nobel Prize	Ryan McBride	10/07/09	Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News	Rebecca Zacks	08/12/09	Boston
Rib-X Antibiotic Passes Clinical Trial, Hopes to Snag Partner	Luke Timmerman	08/05/09	Boston
Rib-X Pharmaceuticals Inc. Lands $25,000,000 Series D Round	VentureDeal	02/04/09	Boston
Exact Teams With Genzyme, Shrugs off Sequenom; Virtual Computer Reels in $15M; Beacon Power Inks National Grid Agreement; & More Boston-Area Deal News	Rebecca Zacks	01/30/09	Boston
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News	Rebecca Zacks	01/28/09	Boston
Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial	Ryan McBride	01/26/09	Boston
Rib-X Pharmaceuticals Inc. Garners $25,000,000 New Funding	VentureDeal	01/26/09	Boston
Rib-X Reveals “Positive” Antibiotic Data	Ryan McBride	12/08/08	Boston
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News	Rebecca Zacks	10/08/08	Boston
Rib-X Pharma, and Its Lead Antibiotic, Gear Up for Prime Time	Ryan McBride	10/02/08	Boston
Page 2 of 2	« previous page

Xconomy National